Palisade Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.7M Sell
62,276
-1,333
-2% -$287K 1.45% 20
2026
Q1
$13.8M Sell
63,609
-34
-0.1% -$7.54K 1.39% 23
2025
Q4
$14.5M Sell
63,643
-1,449
-2% -$330K 1.42% 26
2025
Q3
$15.1M Sell
65,092
-219
-0.3% -$44.6K 1.4% 22
2025
Q2
$12.1M Sell
65,311
-1,312
-2% -$244K 1.21% 31
2025
Q1
$14M Sell
66,623
-22,130
-25% -$4.3M 1.43% 25
2024
Q4
$15.8M Sell
88,753
-1,215
-1% -$223K 1.6% 17
2024
Q3
$17.8M Buy
89,968
+199
+0.2% +$37.1K 1.74% 14
2024
Q2
$15.4M Sell
89,769
-7,572
-8% -$1.25M 1.59% 17
2024
Q1
$17.7M Buy
97,341
+38,562
+66% +$6.65M 1.73% 14
2023
Q4
$9.11M Sell
58,779
-132
-0.2% -$19.2K 1% 36
2023
Q3
$8.78M Sell
58,911
-300
-0.5% -$44K 1.07% 30
2023
Q2
$7.98M Hold
59,211
0.93% 38
2023
Q1
$9.44M Sell
59,211
-14,614
-20% -$2.23M 1.16% 28
2022
Q4
$11.9M Buy
73,825
+14,289
+24% +$2.19M 1.37% 20
2022
Q3
$7.99M Sell
59,536
-250
-0.4% -$35.9K 1.1% 31
2022
Q2
$9.16M Sell
59,786
-94
-0.2% -$14.4K 1.18% 29
2022
Q1
$9.71M Sell
59,880
-386
-0.6% -$56.1K 1.11% 32
2021
Q4
$8.16M Buy
60,266
+403
+0.7% +$47.6K 0.91% 39
2021
Q3
$6.46M Buy
59,863
+588
+1% +$67.2K 0.79% 46
2021
Q2
$6.68M Buy
59,275
+64
+0.1% +$7.21K 0.79% 45
2021
Q1
$6.41M Buy
59,211
+1,100
+2% +$118K 0.82% 45
2020
Q4
$6.23M Buy
58,111
+35
+0.1% +$3.36K 0.85% 44
2020
Q3
$5.09M Sell
58,076
-250
-0.4% -$23.5K 0.77% 45
2020
Q2
$5.73M Sell
58,326
-14,530
-20% -$1.28M 0.91% 41
2020
Q1
$5.55M Sell
72,856
-425
-0.6% -$36.2K 1.01% 37
2019
Q4
$6.49M Buy
73,281
+357
+0.5% +$29.6K 0.95% 41
2019
Q3
$5.52M Buy
72,924
+135
+0.2% +$9.26K 0.84% 45
2019
Q2
$5.29M Buy
72,789
+275
+0.4% +$21.6K 0.82% 45
2019
Q1
$5.84M Sell
72,514
-497
-0.7% -$40.7K 0.93% 43
2018
Q4
$6.73M Buy
73,011
+280
+0.4% +$24.6K 0.99% 40
2018
Q3
$6.88M Buy
72,731
+465
+0.6% +$44.1K 0.91% 40
2018
Q2
$6.7M Buy
72,266
+815
+1% +$79.6K 0.97% 40
2018
Q1
$6.76M Buy
71,451
+145
+0.2% +$15.9K 1.02% 40
2017
Q4
$6.9M Sell
71,306
-150
-0.2% -$14.1K 1.09% 37
2017
Q3
$6.35M Buy
71,456
+3,145
+5% +$239K 1.15% 35
2017
Q2
$4.95M Buy
68,311
+10,381
+18% +$698K 0.97% 35
2017
Q1
$3.77M Sell
57,930
-400
-0.7% -$25.1K 0.69% 40
2016
Q4
$3.65M Sell
58,330
-1,675
-3% -$102K 0.7% 41
2016
Q3
$3.79M Buy
60,005
+749
+1% +$48.5K 0.7% 41
2016
Q2
$3.67M Buy
59,256
+892
+2% +$54.4K 0.69% 44
2016
Q1
$3.33M Buy
58,364
+1,375
+2% +$76.6K 0.65% 43
2015
Q4
$3.38M Sell
56,989
-954
-2% -$54.9K 0.72% 42
2015
Q3
$3.15M Sell
57,943
-684
-1% -$44.5K 0.71% 44
2015
Q2
$3.94M Buy
58,627
+67
+0.1% +$4.37K 0.78% 36
2015
Q1
$3.43M Buy
58,560
+1,375
+2% +$83.1K 0.67% 40
2014
Q4
$3.74M Sell
57,185
-644
-1% -$40.6K 0.74% 37
2014
Q3
$3.34M Sell
57,829
-700
-1% -$38.9K 0.69% 38
2014
Q2
$3.3M Hold
58,529
0.69% 38
2014
Q1
$3.01M Sell
58,529
-100
-0.2% -$5.05K 0.66% 40
2013
Q4
$3.1M Buy
58,629
+581
+1% +$28.6K 0.7% 40
2013
Q3
$2.6M Sell
58,048
-4,130
-7% -$183K 0.66% 41
2013
Q2
$2.57M Buy
+62,178
New +$2.72M 0.65% 44

Other funds holding ABBV

Palisade Asset Management's ABBV Position: Q2 2026 in Review

Palisade Asset Management reduced its AbbVie (ABBV) stake by 2.1% in Q2 2026, selling an estimated $287K and leaving 62,276 shares worth $15.7M. The position accounts for 1.45% of the portfolio, ranked #20.

Palisade Asset Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $17.8M in Q3 2024. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Palisade Asset Management held 62,276 shares of AbbVie worth $15.7M as of Q2 2026.
  • Palisade Asset Management sold 1,333 AbbVie shares in Q2 2026, an estimated $287K.
  • AbbVie made up 1.45% of Palisade Asset Management's portfolio in Q2 2026, its #20 holding.
  • Palisade Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • Palisade Asset Management's AbbVie position peaked at $17.8M in Q3 2024.
  • 4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Palisade Asset Management's 13F filing for Q2 2026, filed 20 Jul 2026.